François Cherifi, Medical Doctor at Centre François Baclesse, shared a post on LinkedIn:
“I am deeply grateful to Gilead Sciences for awarding me the Gilead Scholarship at ESMO2025, which will support my research on evaluating homologous recombination and the response to PARP inhibitors in breast cancer using tumor organoids. This opportunity is a significant step toward developing a companion diagnostic test, and I am excited to contribute to advancing precision oncology.
Thank you, Gilead, for your commitment to scientific innovation and for empowering researchers like me to make a difference!”
More from ESMO2025.
